Cobimetinib

Pronunciation

An orally bioavailable small-molecule inhibitor of mitogen-activated protein kinase kinase 1 (MAP2K1 or MEK1), with potential antineoplastic activity. Cobimetinib specifically binds to and inhibits the catalytic activity of MEK1, resulting in inhibition of extracellular signal-related kinase 2 (ERK2) phosphorylation and activation and decreased tumor cell proliferation. Preclinical studies have demonstrated that this agent is effective in inhibiting the growth of tumor cells bearing a B-RAF mutation, which has been found to be associated with many tumor types. A threonine-tyrosine kinase and a key component of the RAS/RAF/MEK/ERK signaling pathway that is frequently activated in human tumors, MEK1 is required for the transmission of growth-promoting signals from numerous receptor tyrosine kinases. (NCI Thesaurus)

YOU MAY ALSO LIKE

Cobblestone Area-Forming Cells

The number of hematopoietic stem cells (HSCs) that migrate between or beneath a co-cultured feeder cell layer and become trapped. When HSCs…

Cobb Syndrome

A rare congenital but non-hereditary disorder characterized by angiomas or arteriovenous malformations of the spinal cord. Clinical signs include sudden onset of…

Cobaltous Sulfate

A reddish, toxic, metallic salt. Cobalt sulfate is used in the electrochemical industries, as a drier in paints and inks, as a…

Cobaltous chloride Co-57

A radioactive salt of the metal cobalt. Cobalt chloride Co-57 is a radiopharmaceutical used in nuclear medicine as an imaging agent in…

Cobaltous Cation

Cobalt ion requiring two electrons to return to its elemental state.

Cobalt-60 Radiation Therapy

Radiation therapy using gamma radiation generated from cobalt-60.